What is the recommended management for sacroiliac joint pain when plain‑film X‑ray is normal?

Management of Sacroiliac Joint Pain with Normal X-rays

For sacroiliac joint pain without X-ray abnormalities, begin with conservative management (physical therapy, NSAIDs, activity modification) for at least one month, then proceed to image-guided diagnostic/therapeutic corticosteroid injection if 3 or more physical exam provocation maneuvers are positive, followed by radiofrequency ablation if injections provide temporary relief. 1, 2

Diagnostic Approach

The absence of X-ray abnormalities is expected and does not rule out SIJ pain—imaging adds little diagnostic value unless inflammatory spondyloarthropathy is suspected 2. The SIJ accounts for 15-30% of chronic low back pain cases 2, 3.

Clinical Diagnosis Criteria

Physical examination is your primary diagnostic tool:

• Test 6 provocative maneuvers: Patrick's Test, Thigh Thrust, Gaenslen's Test, Distraction, Compression, and Sacral Thrust
• When 3 of 6 are positive: sensitivity 94%, specificity 78% for SIJ pain 2
• When only 2 positive: specificity drops to 66%
• When only 1 positive: specificity drops to 44%

Exception: In patients with predisposing factors (pelvic trauma, spondyloarthritis, prior L5-S1 fusion), 1-2 positive maneuvers may suffice due to higher disease prevalence 2.

Treatment Algorithm

First-Line Conservative Management (Minimum 1 Month)

Before considering interventional procedures, patients should have:

• Pain present >1 month with intensity >4/10 2
• Trial of over-the-counter NSAIDs
• Physical therapy addressing posture and gait disturbances 4
• Activity modification and SI belt use 5

Caveat: Injections may be appropriate earlier if pain causes significant functional limitation despite conservative management 2.

Second-Line: Image-Guided Corticosteroid Injection

Critical point: Fluoroscopic guidance is essential—blind injections have unacceptably low accuracy 2.

Injection protocol:

• Use fluoroscopy, ultrasound, or CT guidance 2
• Inject local anesthetic + corticosteroid intra-articularly
• Serves both diagnostic and therapeutic purposes 2
• Evidence level: 1B+ for intra-articular corticosteroid injections 4

Expected outcomes: Some patients achieve pain relief >3 months 3. The 2022 ASPN guideline gives a "strong recommendation" for SIJ injection for short-term relief 1, though the 2025 BMJ guideline highlights significant inconsistency across guidelines 1.

Repeat injection criteria 2:

• ≥75% relief from diagnostic local anesthetic injection, OR
• ≥50% relief lasting ≥2 months after first injection

Third-Line: Radiofrequency Ablation

If corticosteroid injections provide only temporary relief, proceed to radiofrequency denervation:

• Target: L5 dorsal ramus and S1-3 (or S4) lateral branches 3, 4
• Best evidence: Cooled radiofrequency ablation with extensive lesioning strategies 3
• Evidence level: 2B+ for cooled RF; 2C+ for conventional/pulsed RF 4

The 2020 NICE guideline recommends performing radiofrequency denervation only after positive response to medial branch block 1, while the 2022 ASPN guideline gives a "strong recommendation" for SIJ denervation/ablation 1.

Safety Profile

SIJ injections are generally safe 2:

• Common side effects: Injection-site soreness (most common), pain exacerbations, vasovagal reactions, facial flushing/sweating (steroid-specific), transient sciatic nerve block with fall risk
• Bleeding risk: Low—most guidelines recommend continuing anticoagulation 2
• In one series of 191 injections: 5 immediate adverse events (4 vasovagal, 1 technical), 32 delayed events (mostly injection-site soreness) 2

Important Caveats

Guideline inconsistency: The 2025 BMJ guideline emphasizes that "there was no consistency in recommendations for or against any interventional procedure" across 21 clinical practice guidelines 1. This reflects genuine uncertainty in the evidence base, with positive results three times more likely when reviews are authored by interventionalists versus non-interventionalists 1.

Diagnostic block limitations: Even image-guided diagnostic injections have false-positive and false-negative results 3, 4. The diagnostic value remains controversial 3.

Progression to surgery: Minimally invasive SI arthrodesis is reserved for patients with >75% relief from SI injection, failure of nonsurgical treatment, and continued/recurrent pain 5. This is typically a last resort after exhausting conservative and interventional options.